The impact of obesity on oesophageal acid exposure time on and off proton pump inhibitor therapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|42|9|1093-1100

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.42, Iss.9, 2015-11, pp. : 1093-1100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The impact of obesity on oesophageal acid exposure time on and off proton pump inhibitor therapy

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 269-2813, Iss. 9, 2015-11 ,pp. : 1093-1100

John Wiley & Sons Inc

Access to resources Recommend Favorite

Abnormal esophageal acid exposure on high‐dose proton pump inhibitor therapy is common in systemic sclerosis patients

By  

NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol. 30, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Proton Pump Inhibitor Therapy and Osteoporosis

By  

Current Drug Safety, Vol. 3, Iss. 3, 2008-01 ,pp. : 204-209

Bentham Science Publishers

Access to resources Recommend Favorite

Basophil infiltration in eosinophilic oesophagitis and proton pump inhibitor‐responsive oesophageal eosinophilia

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 8, 2015-04 ,pp. : 776-784

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial: proton pump inhibitor‐responsive oesophageal eosinophilia ‐ two different phenotypes?

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 4, 2015-08 ,pp. : 485-487

John Wiley & Sons Inc

Access to resources Recommend Favorite